- NEWS FEATURE
What the Omicron wave is revealing about human immunity
A health worker in the Philippines prepares a dose of COVID-19 vaccine during the January surge of Omicron cases. Credit: Basilio Sepe/ZUMA Wire/Shutterstock
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 602, 22-25 (2022)
doi: https://doi.org/10.1038/d41586-022-00214-3
References
Andrews, N. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.14.21267615 (2021).
Tseng, H. F. et al. Preprint at medRxiv https://doi.org/10.1101/2022.01.07.22268919 (2021).
Long, Q-.X. et al. Nature Med. 26, 1200–1204 (2020).
Ibarrondo, F. J. et al. N. Engl. J. Med. 383, 1085–1087 (2020).
Cohen, K. W. et al. Cell Rep. Med. 2, 100354 (2021).
Goel, R. R. et al. Science 374, eabm0829 (2021).
Swadling, L. et al. Nature 601, 110–117 (2022).
Keeton, R. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.26.21268380 (2021).
Gao, Y. et al. Nature Med. https://doi.org/10.1038/s41591-022-01700-x (2022).
Chen, J. S. et al. Sci. Immunol. https://doi.org/10.1126/sciimmunol.abl5652 (2021).
Garcia-Beltran, W. F. et al. Cell https://doi.org/10.1016/j.cell.2021.12.033 (2021).
Tarke, A. et al. Cell https://doi.org/10.1016/j.cell.2022.01.015 (2022).
UK Health Security Agency. SARS-CoV-2 Variants of Concern and Variants Under Investigation in England: Technical Briefing 33 (2021).
Slifka, M. A. & Amanna, I. J. Front. Immunol. https://doi.org/10.3389/fimmu.2019.00956 (2019).
Stuart, A. S. V. et al. Lancet 399, 36–49 (2022).
Where did Omicron come from? Three key theories
COVID vaccine immunity is waning — how much does that matter?
‘Killer’ immune cells still recognize Omicron variant
How does Omicron spread so fast? A high viral load isn’t the answer
How COVID unlocked the power of RNA vaccines
The race to make vaccines for a dangerous respiratory virus